Welcome to the Hologic Investor Relations page
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products. The Company’s core business units focus on diagnostics, breast health, GYN surgical, and skeletal health. With a unified suite of technologies and a robust research and development program, Hologic is dedicated to The Science of Sure.
The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol "HOLX".
Monday, December 1, 2014
Hologic Enters the Viral Load Market with CE Mark Certification for the Aptima HIV-1 Viral Load Test
Thursday, November 6, 2014
President and CEO Steve MacMillan on CNBC Squawk Box
Friday, October 31, 2014
The Centers for Medicare and Medicaid Services Issues Ruling on 2015 Reimbursement Rates
Wednesday, October 1, 2014
It's "Genius": Hologic Launches New Consumer Awareness Campaign for Its Breakthrough 3D Mammography Technology